Science Current Events | Science News | Brightsurf.com
 

Autoimmune Current Events | Autoimmune News | 3

Sort By: Page Views | Date

Researcher tricks immune system in diabetic mice
The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it.   view more (2008-11-21)

Johns Hopkins researchers discover key protein linked to transverse myelitis and multiple sclerosis
Hopkins researchers have discovered a single molecule that is a cause of an autoimmune disease in the central nervous system, called transverse myelitis (TM), that is related to multiple sclerosis.   view more (2005-09-23)

Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases
In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune... view more... (2007-04-11)

UNH Glycomics Center Helps Identify Sugar Linkage That Could Lead To Better Treatment For Autoimmune Diseases
Researchers at the University of New Hampshire Glycomics Center have helped identify a specific carbohydrate structure that confers anti-inflammatory activity to a glycoprotein antibody that could lead to improved treatment of autoimmune diseases like lupus or rheumatoid arthritis.   view more (2008-05-14)

Natural compounds block autoimmune response in diabetes, arthritis
Natural compounds derived from a sea anemone extract and a shrub plant have been found to block the autoimmune disease response in type-1 diabetes and rheumatoid arthritis.   view more (2006-11-07)

Common bacteria activating natural killer T cells may cause autoimmune liver disease
A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC).   view more (2008-05-15)

Regulatory T cells require WASp if they are to prevent self-destruction
In humans, mutation of the gene encoding a protein known as WASp leads to susceptibility to infections and systemic autoimmunity.   view more (2007-01-12)

U of M begins nation's first clinical trial using T-reg cells from cord blood in leukemia treatment
University of Minnesota researchers have initiated a ground breaking clinical trial to determine the optimal dose and safety of T regulatory cells (T-regs) to decrease the risk of immune reactions common in patients undergoing blood and marrow transplantation.   view more (2007-09-06)

Adult stem cells may be beneficial for certain cardiovascular disorders and autoimmune diseases
A review of previously published research suggests that stem cells harvested from an adult's blood or marrow may provide treatment benefit to select patients for some autoimmune diseases and cardiovascular disorders.   view more (2008-02-27)

New pathways for autoimmune treatment identified
A rare genetic defect that can trigger a host of diseases from type 1 diabetes to alopecia has helped explain the imbalance of immune regulator and killer cells in autoimmune disease.   view more (2006-05-30)

U-M study offers new perspective on nitric oxide signaling in rheumatoid arthritis
Scientists at the University of Michigan Medical School have found evidence that challenges current thinking about the cause of rheumatoid arthritis (RA), a chronic inflammatory disease that damages joints, causes pain, loss of movement, and bone deformities in 2.1 million Americans.   view more (2006-10-31)

Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers
A research team led by Dr. Ciriaco A. Piccirillo of McGill University's Department of Microbiology and Immunology has discovered that in some individuals, the specialized immunoregulatory T-cells that regulate the body's autoimmune reactions may lose their effectiveness and become "lazy" over time, leading to the onset of type 1 diabetes.   view more (2008-01-16)

Cancer drug may be remedy for rheumatoid arthritis, Stanford study finds
The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis.   view more (2006-09-29)

Accumulated bits of a cell's own DNA can trigger autoimmune disease
A security system wired within every cell to detect the presence of rogue viral DNA can sometimes go awry, triggering an autoimmune response to single-stranded bits of the cell's own DNA, according to a report in the August 22nd issue of the journal Cell, a Cell Press publication.   view more (2008-08-22)

Green tea may delay onset of type 1 diabetes
A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say.   view more (2008-10-24)

Deficient regulators in the immune system responsible for type 1 diabetes
The main regulators of the immune system, called CD4+Treg cells, are thought to be highly involved in a large range of immune diseases.   view more (2008-01-25)

M.D. Anderson-led team reports possible key to autoimmune disease
A human peptide that acts as a natural antibiotic against invading microbes can also bind to the body's own DNA and trigger an immune response in the absence of an infection, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in an early online publication in Nature.   view more (2007-09-17)

Study aims to induce recovery from ankylosing spondylitis
Chinese patients will soon have the opportunity to take part in a study of a novel therapy aimed at reversing the autoimmune disease, ankylosing spondylitis.   view more (2009-07-22)

Prevention is the best option: fighting autoimmune diseases
Centenary scientist Associate Professor Barbara Fazekas de St. Groth, a leader in inflammatory bowel disease research, has demonstrated for the first time the important role of T cells in the prevention of autoimmune diseases in humans.   view more (2006-07-07)

MGH initiates phase I diabetes trial
Scientists at the Massachusetts General Hospital (MGH) have initiated a phase 1 clinical trial to reverse type 1 diabetes.   view more (2008-03-14)
Sort By: Page Views | Date
© 2009 BrightSurf.com